Default company panoramic image
Logo

Biomimetic Electrospinning Technologies

BET develops biomimetic scaffolds for research, and wound healing as well as producing tissue engineered substitutes for diseased tissues.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Seattle, WA, USA
  • Currency USD
  • Founded October 2011
  • Employees 1
  • Website biomimeticespintech.com

Company Summary

BET uses a novel electrospinning technique to produce fibroporous scaffolds that mimic native tissues. These scaffolds are used for research, wound healing, and tissue engineering (TE). The limitation in existing TE is that the engineered tissues don't perform like native tissue. Our technology doesn’t have this limitation thus providing a differential advantage for researchers, clinicians, and health care institutes that use our products.

Team

  • Default avatar
    Stuart Brian Mitchell
    President

    Dr. Mitchell is the founder of BET. He developed the technology for making tissue engineering scaffolds that mimic native tissue structural architectures and mechanical properties. Dr Mitchell is a biomedical scientist who specializes in tissue engineering, biomechanics, biomedical instrumentation and control systems. He has been involved in biomedical engineering for 19 years prior to which his experience was in small business management.

Advisors

  • Default avatar
    Legal Zoom
    Lawyer
    Unconfirmed
    Default avatar
    Tom Mcferson
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Stuart B Mitchell, PhD
    Unconfirmed
    Default avatar
    Jean M Maixner, DVM
    Unconfirmed